| Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 497.50M | £ 510.40M | £ 472.60M | £ 401.00M | £ 393.30M |
| Gross Profit | £ 497.50M | £ 510.40M | £ 472.60M | £ 401.00M | £ 393.30M |
| Operating Income | £ 73.40M | £ 58.10M | £ 45.40M | £ 49.40M | £ 50.40M |
| EBITDA | £ 100.20M | £ 82.70M | £ 67.10M | £ 71.20M | £ 75.50M |
| Net Income | £ 48.20M | £ 39.50M | £ 5.40M | £ 47.40M | £ 41.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 65.30M | £ 45.00M | £ 6.40M | £ 19.80M | £ 5.80M |
| Total Assets | £ 863.10M | £ 692.10M | £ 596.40M | £ 620.10M | £ 531.50M |
| Total Debt | £ 154.30M | £ 97.70M | £ 20.80M | £ 27.00M | £ 32.30M |
| Net Debt | £ 89.00M | £ 52.70M | £ 14.40M | £ 7.20M | £ 26.50M |
| Total Liabilities | £ 481.10M | £ 335.80M | £ 217.90M | £ 202.00M | £ 178.70M |
| Stockholders' Equity | £ 382.00M | £ 356.30M | £ 378.50M | £ 418.10M | £ 352.80M |
| Cash Flow | |||||
| Free Cash Flow | £ -5.60M | £ 11.40M | £ 31.70M | £ 46.00M | £ 45.50M |
| Operating Cash Flow | £ 84.60M | £ 81.00M | £ 65.90M | £ 80.50M | £ 75.70M |
| Investing Cash Flow | £ -85.70M | £ -47.60M | £ -39.40M | £ -30.50M | £ -34.90M |
| Financing Cash Flow | £ 43.30M | £ -37.30M | £ -40.20M | £ -35.80M | £ -50.40M |
Chemring (DE:CMN1)
FRANKFURT:CMN1
